The reason I'm sick of hearing about it is that he hasn't accomplished anything yet for patients and shareholders in the way of approved drugs and/or share price growth and yet he's already got a center named after him, funded, no doubt, by all his stock sales. In that context, news of the center is grating and irritating, like putting the cart before the horse. In a different context, where patient's and shareholder' interests have seen significant advancement from where they currently are, news of his center would be much more well received.